Optimizing the timing of 4CMenB vaccination in adolescents and young adults based on immune persistence and booster response data

• Autores principales: Philip S. Watson (Autor), Patricia Novy (Autor), Rafik Bekkat-Berkani (Autor), Florence Strubbe (Autor), Angelika Banzhoff (Autor)
• Formato: Libro
• Publicado: Taylor & Francis Group, 2019-04-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Introduction: Meningococcal disease has an incidence peak spread over several years during adolescence and young adulthood in the United States. Meningococcal serogroup B (MenB) vaccines have been introduced relatively recently and may help protect individuals in these age groups. Currently there is...